- Recurring and Accelerated Receipt of Order Reflects Customer Commitment to Linea DNA - STONY BROOK, N.Y., - September 17, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced it has received a follow-on order valued at more than $500,000 for [...]
STONY BROOK, N.Y. September 11, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has launched an expansion of its clinical testing services for the detection of Mpox (formerly monkeypox) to include testing for both mpox [...]
MeiLin Wan is the Vice President of Textile Sales for Applied DNA Sciences, a U.S.-based cotton DNA authentication company that released a report earlier this year highlighting an alarming percentage of imported cotton textiles and apparel made by forced labor in Xinjiang, China. Hear more about the rise in forced labor behind the apparel [...]
STONY BROOK, N.Y. September 4, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced the receipt of a subcontract award from LRQA following a competitive tender for a pilot isotopic testing program. Under the terms of the subcontract, Applied DNA, together with its traceability [...]
STONY BROOK, NY. August 23, 2024 - Applied DNA Sciences, Inc. (NASDAQ:APDN) (the”Company”), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has submitted a validation package to the New York State Department of [...]
STONY BROOK, N.Y., August 19, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced its intention to seek an expansion of the approved intended use of its Linea™ Mpox Virus 1.0 Assay (the “Assay”) to include the detection of mpox Clade I that is the [...]
STONY BROOK, N.Y. – August 8, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for its third fiscal quarter ended June 30, 2024. The Company’s Form 10-Q can be viewed at https://investors.adnas.com/sec-filings/. Third Quarter Operational Highlights [...]
STONY BROOK, N.Y. – August 7, 2024 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its third quarter fiscal 2024 financial results after market close on Thursday, August 8, 2024. In conjunction with this announcement, Applied [...]
Applied DNA Sciences has signed a five-year licensing and commercial-based agreement with vertically integrated textile manufacturer Indus Group for the DNA authentication firm's CertainT platform.